HK36793A - Ketone derivatives as medicaments for the treatment or prevention of the withdrawal syndrome - Google Patents

Ketone derivatives as medicaments for the treatment or prevention of the withdrawal syndrome

Info

Publication number: HK36793A
Authority: HK; Hong Kong
Prior art keywords: prevention; medicaments; treatment; withdrawal syndrome; ketone derivatives
Prior art date: 1986-11-21

Application number

HK367/93A

Other languages

English (en)

Inventor

Michael Brian Tyers

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-11-21

Filing date

1993-04-15

Publication date

1993-04-23

1993-04-15 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1993-04-23 Publication of HK36793A publication Critical patent/HK36793A/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Toxicology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

HK367/93A 1986-11-21 1993-04-15 Ketone derivatives as medicaments for the treatment or prevention of the withdrawal syndrome HK36793A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB868627909A GB8627909D0 (en)	1986-11-21	1986-11-21	Medicaments

Publications (1)

Publication Number	Publication Date
HK36793A true HK36793A (en)	1993-04-23

Family

ID=10607734

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK367/93A HK36793A (en)	1986-11-21	1993-04-15	Ketone derivatives as medicaments for the treatment or prevention of the withdrawal syndrome

Country Status (16)

Country	Link
US (1)	US4847281A (de)
EP (1)	EP0278161B1 (de)
JP (1)	JPH0830008B2 (de)
KR (1)	KR950010148B1 (de)
AT (1)	ATE74271T1 (de)
AU (1)	AU608788B2 (de)
CY (1)	CY1694A (de)
DE (1)	DE3778008D1 (de)
DK (1)	DK612787A (de)
ES (1)	ES2033879T3 (de)
GB (1)	GB8627909D0 (de)
GR (1)	GR3004252T3 (de)
HK (1)	HK36793A (de)
IE (1)	IE61033B1 (de)
PH (1)	PH24934A (de)
ZA (1)	ZA878702B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5198447A (en) *	1986-11-21	1993-03-30	Glaxo Group Limited	Medicaments
JP2765845B2 (ja) *	1986-11-21	1998-06-18	グラクソ、グループ、リミテッド	中止症候群の予防の治療薬
DE3822792C2 (de) *	1987-07-11	1997-11-27	Sandoz Ag	Neue Verwendung von 5HT¶3¶-Antagonisten
US5272168A (en) *	1987-07-11	1993-12-21	Sandoz Ltd.	Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents
US5198459A (en) *	1987-07-11	1993-03-30	Sandoz Ltd.	Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents
GB8820650D0 (en) *	1988-09-01	1988-10-05	Glaxo Group Ltd	Medicaments
US5292752A (en) *	1989-12-21	1994-03-08	Merrell Dow Pharmaceuticals Inc.	Antithrombotic compounds
US5225407A (en) *	1990-02-22	1993-07-06	Glaxo Group Limited	5-HT3 receptor antagonists for the treatment of autism
US5397782A (en) *	1990-06-13	1995-03-14	Janssen Pharmaceutica N.V.	Method of treating addiction to alcohol
EP0591434A4 (en) *	1991-06-26	1994-09-14	Sepracor Inc	Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
GB9310756D0 (en) *	1993-05-25	1993-07-14	Glaxo Lab Sa	Compositions
US5726644A (en) *	1995-06-30	1998-03-10	Philips Electronics North America Corporation	Lighting control system with packet hopping communication
US5824684A (en) *	1997-02-21	1998-10-20	Synapse Pharmaceuticals International, Inc.	Method for treating drug and alcohol addiction
US20080004260A1 (en) *	2006-06-29	2008-01-03	Transcept Pharmaceuticals, Inc.	Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions
US9226918B2 (en) *	2008-12-04	2016-01-05	The Board Of Trustees Of The Leland Stanford Junior University	Methods and compositions for treating or preventing narcotic withdrawal symptoms
US20100298397A1 (en) *	2009-05-19	2010-11-25	Singh Nikhilesh N	Method of treatment of obsessive compulsive disorder with ondansetron
US20110288115A1 (en) *	2010-05-24	2011-11-24	Avmedis Llc	Treatment of vagally-mediated spectrum disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4499096A (en) *	1983-11-18	1985-02-12	Lotsof Howard S	Rapid method for interrupting the narcotic addiction syndrome
AU579132B2 (en) *	1984-01-25	1988-11-17	Glaxo Group Limited	Heterocyclic compounds
DE3688296T2 (de) *	1985-03-14	1993-11-04	Beecham Group Plc	Arzneimittel zur behandlung von erbrechen.
GB8516083D0 (en) *	1985-06-25	1985-07-31	Glaxo Group Ltd	Heterocyclic compounds
NL8701682A (nl) *	1986-07-30	1988-02-16	Sandoz Ag	Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
DE3780276T2 (de) *	1986-12-16	1993-02-25	Robins Co Inc A H	Angstloesende n-(1-azabicyclo(2.2.2)oct-3-yl)benzamide und -thiobenzamide.
DE3822792C2 (de) *	1987-07-11	1997-11-27	Sandoz Ag	Neue Verwendung von 5HT¶3¶-Antagonisten

1986
- 1986-11-21 GB GB868627909A patent/GB8627909D0/en active Pending
1987
- 1987-11-20 DE DE8787310289T patent/DE3778008D1/de not_active Expired - Lifetime
- 1987-11-20 KR KR1019870013069A patent/KR950010148B1/ko not_active IP Right Cessation
- 1987-11-20 JP JP62293894A patent/JPH0830008B2/ja not_active Expired - Lifetime
- 1987-11-20 DK DK612787A patent/DK612787A/da not_active Application Discontinuation
- 1987-11-20 PH PH36099A patent/PH24934A/en unknown
- 1987-11-20 US US07/123,369 patent/US4847281A/en not_active Expired - Lifetime
- 1987-11-20 AT AT87310289T patent/ATE74271T1/de not_active IP Right Cessation
- 1987-11-20 IE IE315687A patent/IE61033B1/en not_active IP Right Cessation
- 1987-11-20 ES ES87310289T patent/ES2033879T3/es not_active Expired - Lifetime
- 1987-11-20 EP EP87310289A patent/EP0278161B1/de not_active Expired - Lifetime
- 1987-11-20 ZA ZA878702A patent/ZA878702B/xx unknown
- 1987-11-20 AU AU81443/87A patent/AU608788B2/en not_active Ceased
1992
- 1992-04-02 GR GR920400436T patent/GR3004252T3/el unknown
1993
- 1993-04-15 HK HK367/93A patent/HK36793A/xx not_active IP Right Cessation
1994
- 1994-01-14 CY CY169494A patent/CY1694A/xx unknown

Also Published As

Publication number	Publication date
ES2033879T3 (es)	1995-04-01
GR3004252T3 (de)	1993-03-31
AU608788B2 (en)	1991-04-18
IE873156L (en)	1988-05-21
KR880005930A (ko)	1988-07-21
JPH0830008B2 (ja)	1996-03-27
GB8627909D0 (en)	1986-12-31
EP0278161B1 (de)	1992-04-01
PH24934A (en)	1990-12-26
ZA878702B (en)	1988-09-28
DK612787A (da)	1988-05-22
EP0278161A1 (de)	1988-08-17
KR950010148B1 (ko)	1995-09-11
DE3778008D1 (de)	1992-05-07
JPS63185927A (ja)	1988-08-01
AU8144387A (en)	1988-05-26
IE61033B1 (en)	1994-09-07
ATE74271T1 (de)	1992-04-15
DK612787D0 (da)	1987-11-20
CY1694A (en)	1994-01-14
US4847281A (en)	1989-07-11

Legal Events

Date	Code	Title	Description
2004-12-15	PF	Patent in force
2005-06-24	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20041120

Publication	Publication Date	Title
CY1694A (en)	1994-01-14	Ketone derivatives as medicaments for the treatment or prevention of the withdrawal syndrome
EP0392959A3 (de)	1992-05-06	Verwendung von Sertindol zur Behandlung von Schizophrenie
AU2711295A (en)	1996-02-01	Combination treatment for inhibiting bone loss
HU9603042D0 (en)	1997-01-28	Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
AU8261787A (en)	1988-06-23	Medicaments for the treatment of depression
GR3006091T3 (de)	1993-06-21
HU901085D0 (en)	1991-09-30	Process for producing substituted benzimidazole and pharmaceutical preparatives containing it
ZA925146B (en)	1993-08-16	Pharmaceutical agent for treatment of withdrawal symptoms.
IL88740A (en)	1993-01-31	Pharmaceutical compositions containing n-n-butyl deoxynojirimycin for treating aids
SE8902458L (sv)	1990-01-08	Laekemedelskomposition
IE873231L (en)	1988-05-28	Medicaments
ZA872443B (en)	1987-11-25	Bis-tert.butylamino-substituted 1,3,5-triazine derivatives,processes for their preparation,medicaments containing these compounds and their use
IT1296613B1 (it)	1999-07-14	Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide.
IL98199A (en)	1997-06-10	Pharmaceutical compositions containing a derivative of substituted l-valyl-l-prolinamide
IL89654A0 (en)	1989-09-28	Pharmaceutical combination preparations for treating hypertension
MX9803271A (es)	1998-09-30	Uso de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,6-tetrahid ropiridina para la preparacion de farmacos para el tratamiento de esclerosis lateral aminotrofica.
MX9703032A (es)	1997-12-31	Nuevas aplicaciones del 5-etoxicarbonil-2,4,6-trimetil-1,4-dihidropiridina-3-carboxi lato de 2-[n-(1,2-benzisotiazolil-3(2h) ona-1,1-dioxido]etilo.